• TABLE OF CONTENTS
HIDE
 Venture capital
 Partnering
 Training
 Start-up success














Title: Commercialization Council venture news
ALL VOLUMES CITATION PDF VIEWER THUMBNAILS PAGE IMAGE ZOOMABLE
Full Citation
STANDARD VIEW MARC VIEW
Permanent Link: http://ufdc.ufl.edu/UF00088889/00006
 Material Information
Title: Commercialization Council venture news
Series Title: Commercialization Council venture news
Physical Description: Serial
Creator: University of Florida Commercialization Council
Publisher: University of Florida Commercialization Council
Publication Date: Winter 2004-5
 Record Information
Bibliographic ID: UF00088889
Volume ID: VID00006
Source Institution: University of Florida
Rights Management: All rights reserved by the source institution and holding location.

Downloads

This item has the following downloads:

VentureNews_Winter04-05 ( PDF )


Table of Contents
    Venture capital
        Page 1
    Partnering
        Page 2
    Training
        Page 2
        Page 3
    Start-up success
        Page 4
        Page 5
        Page 6
        Page 7
Full Text
Venture Newsletter


Commercialization Council
* UNIVERSITY OF

".FLORIDA VENTURE NEWS


'Ceain a llJ Mor Virn nrernuil Cultran Flatili.mn th u-tsl rom rilztno U -ae ehooie "


Winter 2004/2005


Members of the
Commercialization Council

Office of Technology Licensing
David Day Director
Jane Muir Associate Director


Univ. of Florida Foundation
Christopher Needles
Assistant VP/Development


Sid Martin Biotechnology
Development Incubator
Patti Breedlove Incubator Mgr.


The Commercialization Council is involved with a number of very
exciting pursuits, and is gearing up for another great year. In this
issue you'll read about numerous successes bringing technologies
to the marketplace through the collaborative efforts of the UF
Foundation in identifying alum that are interested in becoming
involved in UF start-ups, the technology incubators in nurturing our
young companies, and the Office of Technology Licensing in
identifying technologies that could potentially provide the platform
for a start-up.


VENTURE CAPITAL

UF Tech Alert Gives Investors Front-Row Seat to Cutting-
Edge Technologies

Industry partners and private investors have rave reviews for one
of the University of Florida's most innovative efforts to
communicate with industry partners, a simple web-based service
that instantly notifies subscribers of University of Florida
technologies available for commercialization in their specific areas
of interest. "Companies and investors love it," reports Jane Muir,
Associate Director of the university's Office of Technology
Licensing.

Last Spring the University of Florida unveiled UF TechAlert, a free
service to help its commercial partners identify cutting-edge
technologies that could complement existing product lines, improve
manufacturing processes, or be the basis of a startup company. UF
TechAlert generates a text-only email to subscribers with a web link
to a description of the new discovery and contact data for more
information.

Currently, descriptions of hundreds of technologies available for
licensing are posted on the University of Florida website. Each
month, the university typically posts 8 to twelve new technologies.
As each one is added, UF TechAlert generates an email to
subscribers who have indicated interest in that category either
agriculture, engineering/physical sciences, environment, genomics,
human health care, medical devices, research tools, software,
veterinary, or other.

"We typically receive dozens of requests from company
representatives and investors hunting for technologies in a
particular space," said Muir. "UF TechAlert allows them to be


http://rgp.ufl.edu/otl/venture/ufventure.html


Page 1 of 7


3/21/2005




Venture Newsletter Page 2 of 7


The Commercialization Council
is funded by the
Office of the Vice President for
Research

Dr. Winfred M. Phillips
Vice President for Research

PO Box 115500
(352) 392-1582
http://rgp.ufl.edu


The UFCC Venture e-newsletter is
sent to you by the University of
Florida Commercialization Council.

To be removed from the UFCC
Venture mailing list, please email
jmuir@ufl.edu.


The information contained in UFCC
Venture may not be reproduced
without the permission of the
University of Florida
Commercialization Council.


proactive by subscribing to technology areas, and regularly
receiving only relevant technologies."

To subscribe to UF TechAlert, simply go to this URL,
http://apps.rgp.ufl.edu/otl/tech_updatesl.cfm.

For more information, contact Jane Muir at jmuir@ufl.edu or at
(352) 392-8929.


Return to top





PARTNERING

EDA University Center Director Takes Helm of Gainesville
Area Innovation Network

The Gainesville Area Innovation Network (GAIN) is a group of local
investors, inventors, entrepreneurs, business people, professionals,
professors, and service providers who share ideas, energy and
talents. Formed in 1985 to provide networking and educational
opportunities to assist and encourage the entrepreneurial interests
of its members, GAIN hosts monthly luncheons featuring
community shapers such as Mayor Pegeen Hanrahan, UF Vice
President for Research Dr. Win Philips, and many CEO's of local
technology-based start-up companies.

GAIN announced recently its selection of Jane Muir as president.
Muir's focus during her tenure as president will be to enhance
member services and enlist greater involvement of members. She
is also Director of the University of Florida EDA University Center
and Associate Director of the Office of Technology Licensing.

GAIN meets the last Wednesday of every month and is open to the
public. To attend a luncheon meeting, RSVP through the GAIN
website at www.gain-net.org or contact Linda Garcia at (352)
466-4387.

Return to top


TRAINING

UF Faculty Attend Entrepreneurship Training


Faculty members interested in learning how to start a technology-
based company attended the Entrepreneur Series this fall at the
McKnight Brain Institute. The series included an introduction to
intellectual property at UF, presented by David Day, Director of the
Office of Technology Licensing, as well as a presentation on raising
capital by UF alum Dr. Steven Snowdy of MB Ventures. Sara


http://rgp.ufl.edu/otl/venture/ufventure.html


3/21/2005




Venture Newsletter Page 2 of 7


The Commercialization Council
is funded by the
Office of the Vice President for
Research

Dr. Winfred M. Phillips
Vice President for Research

PO Box 115500
(352) 392-1582
http://rgp.ufl.edu


The UFCC Venture e-newsletter is
sent to you by the University of
Florida Commercialization Council.

To be removed from the UFCC
Venture mailing list, please email
jmuir@ufl.edu.


The information contained in UFCC
Venture may not be reproduced
without the permission of the
University of Florida
Commercialization Council.


proactive by subscribing to technology areas, and regularly
receiving only relevant technologies."

To subscribe to UF TechAlert, simply go to this URL,
http://apps.rgp.ufl.edu/otl/tech_updatesl.cfm.

For more information, contact Jane Muir at jmuir@ufl.edu or at
(352) 392-8929.


Return to top





PARTNERING

EDA University Center Director Takes Helm of Gainesville
Area Innovation Network

The Gainesville Area Innovation Network (GAIN) is a group of local
investors, inventors, entrepreneurs, business people, professionals,
professors, and service providers who share ideas, energy and
talents. Formed in 1985 to provide networking and educational
opportunities to assist and encourage the entrepreneurial interests
of its members, GAIN hosts monthly luncheons featuring
community shapers such as Mayor Pegeen Hanrahan, UF Vice
President for Research Dr. Win Philips, and many CEO's of local
technology-based start-up companies.

GAIN announced recently its selection of Jane Muir as president.
Muir's focus during her tenure as president will be to enhance
member services and enlist greater involvement of members. She
is also Director of the University of Florida EDA University Center
and Associate Director of the Office of Technology Licensing.

GAIN meets the last Wednesday of every month and is open to the
public. To attend a luncheon meeting, RSVP through the GAIN
website at www.gain-net.org or contact Linda Garcia at (352)
466-4387.

Return to top


TRAINING

UF Faculty Attend Entrepreneurship Training


Faculty members interested in learning how to start a technology-
based company attended the Entrepreneur Series this fall at the
McKnight Brain Institute. The series included an introduction to
intellectual property at UF, presented by David Day, Director of the
Office of Technology Licensing, as well as a presentation on raising
capital by UF alum Dr. Steven Snowdy of MB Ventures. Sara


http://rgp.ufl.edu/otl/venture/ufventure.html


3/21/2005




Venture Newsletter


Sehgal, a Silicon Valley accountant with Frank, Rimerman and Co.,
LLP, helped participants understand the importance of accounting
and legal structure for a company's success.

Les Croland, a partner with Edwards and Angell, LLP, spoke with
participants about how to prepare a business plan that will help
investors understand their company. Croland emphasized the
importance of an experienced management team. "Work with
experienced professionals," he recommended to the audience of
20, mainly faculty members and a few graduate students, "and
retain a CEO with business experience."

The Entrepreneur Series is presented by the UF Commercialization
Council twice yearly to help introduce faculty members to the world
of business creation and entrepreneurship.

UF Early Stage Series: The Winning Pitch & How to Assemble
a Board

Thirty entrepreneurs from the UF family gained practical insights
and heard the voices of experience during the UF Early Stage
Series. The series was designed to help start-up companies
escalate to the next level, and was sponsored by the UF
Commercialization Council, BioFlorida, the UF EDA University
Center, Office of Technology Licensing, Gainesville Council for
Economic Outreach, and Hutchison & Mason, PLLC.

The first event, "Telling Your Story: The One-Minute Value
Proposition," was held in September at the Gainesville Technology
Enterprise Center (GTEC). Kim Marinucci, an expert in developing
and presenting value propositions for start-up firms, helped a
number of our early stage companies come up with their "elevator
pitch," a succinct statement of the purpose and benefit of the
company. She also provided one-on-one coaching.

In December, Sue Washer, CEO of AGTC, and members of the
AGTC Board of Directors gave a panel presentation on "The
Importance of Assembling a Strong Board of Directors." Over 30
participants heard strategies and techniques for assembling the
right Board for a company and concrete examples of how strong
Board members can enhance a company's success. Also featured
were David Lowe, partner with Skyline Ventures, and Scott Koenig,
CEO of Macrogenics, Inc.

SEBIO Tremendous Success for UF

SEBIO's first trip to the Sunshine State was a sweeping success for
the UF community. Held in November at the Doral Golf Resort &
Spa in Miami, the 6th Annual Southeastern Bio Investor Conference
(SEBIO) gave investors an opportunity to hear presentations from
some of the region's hottest early-stage technology firms seeking
funding. The conference is an event of the Southeastern Life
Sciences Association (SELSA), a regional collaboration of leading
organizations from life sciences, entrepreneurship, and venture
capital, from both the public and private sectors.

Osprey Pharmaceutical Company and Banyan Biomarkers gave
presentations to numerous venture capital firms and billions of


http://rgp.ufl.edu/otl/venture/ufventure.html


Page 3 of 7


3/21/2005




Venture Newsletter Page 4 of 7


potential investment dollars. Each caught the eyes of some key
players.

Event co-chairs David Day, Director of the University of Florida's
Office of Technology Licensing and a founding member of SEBIO,
and David Gury, Chairman of NABI Biopharmaceuticals, were very
pleased with the turnout and the level of interest by investors at
the conference. "This was one of the better deal-making
opportunities of the year," said Day, "I'm eager to see many of
these companies receive the funding they need to enable them to
get these innovative products to the marketplace." Patti Breedlove,
Manager of the Sid Martin Biotechnology Development Institute,
served as Recruitment Chair for the event.

Forty Attend Funding for Researchers & Start-Up Companies

Forty participants representing the area's fastest rising technology
start-ups attended this year's presentation on funding opportunities
through the Small Business Innovation Research (SBIR) and Small
Business Technology Transfer (STTR) programs. The instructors,
Jim and Gail Greenwood, are nationally known for their expertise
and success in helping companies navigate the SBIR/STTR
application process to secure federal funds funds that don't have
to be paid back. "We appreciate the opportunity to help prepare
these UF companies for the application process," said Gail
Greenwood, "because the funds are a great tool to get really solid
technologies over the financial hurdles that may otherwise seem
insurmountable."

In their morning session, the Greenwoods gave an overview of the
SBIR/STTR programs and highlighted recent trends and anticipated
changes, as well as giving practical instructions on how to identify
the topic and agency that best fits a company's technology. The
afternoon session focused on individual technology areas: life
sciences, homeland security, information technology, and defense.
Participants also learned about budgets and indirect rates, audits,
and IP rights, and had an opportunity to ask specific questions and
hear feedback about their applications.

The University of Florida Commercialization Council sponsored the
event, along with the Gainesville Area Innovation Network (GAIN),
UF's EDA University Center and the Office of Technology Licensing.

Return to top




START-UP SUCCESS

UF Start-Up Oragenics' FDA Approval Big News

The New York Times featured a story about Oragenics, a University
of Florida spin-off company that recently received FDA approval to
begin clinical trials on a single, painless topical treatment that could
offer life-long protection from most tooth decay. This momentous
announcement is one in a long series of smaller successes leading
Jeffrey Hillman's invention from the UF benchtop to the worldwide


http://rgp.ufl.edu/otl/venture/ufventure.html


3/21/2005




Venture Newsletter


marketplace.

Dr. Hillman, UF professor and Oragenics chief scientific officer, has
been working on this therapy for 25 years and first applied to the
FDA for permission to begin a clinical trial in 1998. Start-up
companies and large firms alike can expect a fair amount of
dialogue back and forth with the FDA when seeking approval to
conduct human trials. "The F.D.A. has its failsafe," said Chuck
Soponis, Oragenics CEO. Oragenics, for example, agreed that the
15 volunteers in the first trial will not even have teeth they will
have dentures. That way, if something unexpected happens, the
dentures can be plopped into bleach to inactivate the treatment,
which mainly sticks to teeth.

If all goes well with this safety trial and future trials on
effectiveness, Oragenics anticipates the treatment could reach the
market by 2009 or 2010. But the more immediate next step,
according to Soponis, is to attract investors and business partners
to help get the company's treatment through clinical trials.

To read about more Oragenics and other UF start-up companies
that are improving people's lives and creating jobs, go to OTL's
website at www.otl.ufl.edu and click on Start-Up Companies.

Start-Up Company Overviews Now Available on UF
Website
Company descriptions for over twenty UF spin-offs are now
available on the Office of Technology Licensing website at
www.otl.ufl.edu, with more being added regularly. The
company overviews highlight each firm's value proposition,
strategy, management team, technology, and market potential.
They also provide contact information and company website
addresses for those who want to know more.


UF Spin-Off Treats Schizophrenia Symptom

Nearly 4 million people in the U.S. and an estimated 1.5% of the
world's population suffer from schizophrenia; 80% of these patients
also suffer from serious attention-related disorders that accompany
this devastating disease. Unfortunately for these people and their
families, antipsychotic medications currently used to treat
schizophrenia are relatively ineffective in improving the associated
attention-related deficits.

A new company is planning to use a technology developed at the
University of Florida to treat these attention-related deficits
associated with schizophrenia. Osprey Pharmaceutical Company is
focused on DMBXA, a compound that has demonstrated the ability
to significantly improve cognition and memory function. Research
underlying the compound's discovery and characterization was led
by William R. Kem, Ph.D., Professor of Pharmacology and
Therapeutics at UF.

"This is like a dream come true, not only for me and my research
colleagues," says Kem of the process that is taking his discovery to
market, "but especially for those patients and families whose lives
will be vastly improved by this product."


http://rgp.ufl.edu/otl/venture/ufventure.html


Page 5 of 7


3/21/2005




Venture Newsletter Page 6 of 7


UF's Office of Technology Licensing (OTL) introduced Dr. Kem and
his research team to Stefan Borg, an energetic researcher-turned-
executive who agreed to take the helm of the new start-up. "Mr.
Borg's expertise in taking discoveries through the complex,
expensive pharmaceutical trial process makes him an ideal
candidate to commercialize this exciting discovery," said David L.
Day, OTL Director.

According to Borg, "There are so many tremendous needs for new
drugs and UF is very aggressively pursuing ways to move its
cutting-edge research into the marketplace to meet those needs. It
is a very exciting process." Osprey also intends to pursue
treatments of Age-Associated Memory Impairment ("AAMI"), a
condition affecting 30-50% of people over age 55, as well as
cancer, Parkinson's Disease, and smoking cessation.

More information about Osprey Pharmaceutical Company is
available at the OTL website at www.otl.ufl.edu. Click on the
"Start-Up Companies" link.

UF Spin-Off Receives Prestigious National Award

UF spin-off SinMat, Inc. was presented with R&D Magazine's 2004
R&D 100 Award in October. The award represents the opinion of
more than 50 judges professional consultants, university faculty,
and industrial researchers with superior expertise and relevant
experience that SinMat has introduced one of the "100 most
technologically significant products of the year." The company's
Genteel Slurry meets a tremendous need of circuit manufacturers
for a cost-saving, output-enhancing technique to polish the
surfaces of microcircuitry used in products such as Pentium disks, a
task that has no tolerance for defects.

Husband-and-wife leadership team Rajiv and Deepika Singh who
between them hold 25 pending and issued U.S. patents and two
commercial software copyrights are among a prestigious group of
UF inventors to add "entrepreneur" to their lengthy resumes. "This
company is a tremendous opportunity for us to apply our years of
research and expertise to a real-world solution in a very direct
way," says Dr. Rajiv Singh, a UF professor.

Currently located within the Gainesville Technology Enterprise
Center (GTEC), a local incubator facility, SinMat is an excellent
example of the newest extension of Gainesville 's technology
pipeline. UF researchers generate 300 invention disclosures each
year, and an increasing number of those technologies are used as
platforms for start-up companies. The EDA University Center,
housed in the Office of Technology Licensing, routinely facilitates
meetings of investors and experienced entrepreneurs with
entrepreneurially-minded faculty.

For more information about SinMat, visit OTL's website at
www.otl.ufl.edu and click on the "Start-Up Companies" link. For
more information on entrepreneurship training and other related
events, click the Calendar link at the end of this publication.

Return to top


http://rgp.ufl.edu/otl/venture/ufventure.html


3/21/2005




Venture Newsletter


Check here for upcoming events:

Calendar of Events


http://rgp.ufl.edu/otl/venture/ufventure.html


Page 7 of 7


3/21/2005




University of Florida Home Page
© 2004 - 2010 University of Florida George A. Smathers Libraries.
All rights reserved.

Acceptable Use, Copyright, and Disclaimer Statement
Last updated October 10, 2010 - - mvs